This article provides an overview of the complications and related management of laparoscopic radical gastrectomy in China, drawing from both literature and current domestic clinical research progress. Laparoscopic radical gastrectomy in China has undergone vigorous development and continuous innovation over the past 30 years, achieving remarkable results. However, the uneven development across regions remains a current challenge. The overall complication rate and mortality rate of laparoscopic radical gastrectomy for early-staging gastric cancer in China are comparable to those of open surgery. The main complications include intraoperative bleeding, anastomotic leakage, stenosis, postoperative emptying disorders, and so on. Data show that laparoscopic surgery has advantages in reducing some systemic complications. Current research indicates that neoadjuvant therapy, especially chemotherapy combined with immunotherapy (NAIC), can improve the pathological complete response rate (pCR) and radical resection rate (R0) without increasing the risk of postoperative complications. The author believes that continuously promoting the standardization and modularization of laparoscopic radical gastrectomy, emphasizing the concept of mesenteric anatomy, and correctly and reasonably using energy devices can shorten the learning curve of surgeons, reduce the rate of surgical complications, and further improve the overall level of laparoscopic radical gastrectomy in China.